Class Action Filed Against China Liberal Education Over Alleged Securities Fraud

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Class action lawsuit filed against China Liberal Education for alleged securities fraud involving fraudulent social media advisors that artificially inflated stock prices before collapse.

Class Action Filed Against China Liberal Education Over Alleged Securities Fraud

Pomerantz Law Firm has initiated a class action lawsuit against China Liberal Education Holdings Limited (CLEUF), alleging the company engaged in securities fraud through the use of fraudulent social media investment advisors that artificially inflated stock valuations. The scheme allegedly resulted in a significant stock price collapse on January 30, 2025, causing substantial losses for affected investors.

The lawsuit claims that misleading promotional activities via social media channels were used to artificially boost investor demand and stock performance prior to the collapse. Investors who suffered losses during this period may be eligible to participate in the legal action as class members.

Investors who wish to pursue Lead Plaintiff status in the case must file their request by March 31, 2026. The law firm is simultaneously pursuing similar securities fraud claims against other companies, including Bath & Body Works and Vistagen Therapeutics, as part of its broader litigation efforts.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 17

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON